期刊文献+

经皮经腔间隔心肌消融术与室间隔部分切除术治疗梗阻性肥厚型心肌病的Meta分析 被引量:3

Comparison of the effects of ablation or surgery treatment for obstructive hypertrophic cardiomyopathy——a Meta analysis
原文传递
导出
摘要 目的:对比评价经皮经腔间隔心肌消融术(消融)与室间隔部分切除术(手术)治疗梗阻性肥厚型心 肌病(OHCM)的疗效。方法:检索Pubmed,找到3篇对比消融与手术治疗OHCM的文章进行Meta分析。结 果:共计177例患者,86例消融,91例手术。消融使平均室间隔厚度由22.1mm降至15.1mm(P<0.05),手术 使平均室间隔厚度由22.0mm降至13.9mm(P<0.05),两种治疗方法相比较差异无统计学意义(P>0.05); 消融使平均左室流出道(LVOT)压差由10.1kPa降至2.1kPa(P<0.05),手术使平均LVOT压差由9.9kPa降 至1.3kPa(P<0.05),手术优于消融(P<0.05);消融使平均左室舒张末期内径由41.8mm增至45.2mm(P <0.05),手术使平均左室舒张末期内径由41.8mm增至43.9mm(P<0.05),消融与手术相比较差异无统计学 意义(P>0.05);消融使平均NYHA分级由3.17升至1.47(P<0.05),手术使平均HYNA分级由2.97升至 1.36(P<0.05),消融与手术相比较差异无统计学意义(P>0.05)。结论:消融与手术治疗OHCM的客观指标 与主观指标均较为接近,进行消融与手术治疗大规模随机对照试验应是切实可行的也是必要的。 Objective:To compare the effects of percutaneous transluminal septal myocardial ablation ( PTSMA ) with septal myectomy in patients with obstructive hypertrophic cardiomyopathy ( OHCM). Method:Three articles comparing the effects of ablation and surgery treatment for OHCM were identified from search in Pubmed, then a Meta analysis was conducted. Result:One hundred and seventy-seven patients (86 underwent PTSMA and 91 underwent septal myectomy ) were included. Interventricular septum thickness was decreased from 22.1 mm to 15.1 mm (P< 0.05 ) in PTSMA group and from 22.0 mm to 13.9 mm (P< 0.05) in septal myectomy group; left ventricular end-diastolic dimension was increased from 41.8 mm to 45.2 mm (P< 0.05) in PTSMA group and from 41.8 mm to 43.9 mm (P< 0.05) in setpal myectomy group; NYHA class was improved from 3.17 to 1.47 ( P< 0.05 ) in PTSMA group and from 2.97 to 1.36 ( P< 0.05 ) in septal myectomy group; there were no differences in the two groups. However, left ventricular outflow tract gradient was decreased from 10.1 kPa to 2.1 kPa ( P< 0.05 ) in PTSMA group and from 9.9 kPa to 1.3 kPa ( P< 0.05 ) in septal myectomy group and the effect of septal myectomy was better than PTSMA ( P< 0.05 ).Conclusion:The effects of PTSMA for OHCM appear similar to septal myectomy. Large randomized clinical trials further comparing the two treatments are suggested.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第1期59-61,共3页 Journal of Clinical Cardiology
关键词 心肌病 肥厚型 经皮经腔间隔心肌消融术 室间隔部分切除术 META分析 Cardiomyopathy,hypertrophic Percutaneous transluminal septal myocardial ablation Septal myectomy Meta analysis
  • 相关文献

参考文献8

  • 1颜艳 徐勇勇.医学文献的系统综述方法与meta分析[A].见:孙振球主编.医学统计学[C].北京:人民卫生出版社,2002.499-509.
  • 2Nagueh S F, Ommen S R, Lakkis N M, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001 ,38 : 1701- 1706.
  • 3Qin J X, Shiota T, Lever H M, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol,2001 ,38 : 1994- 2000.
  • 4Firoozi S, Elliott P M, Sharma S, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.Eur Heart J,2002 ,23:1617-1624.
  • 5Sitges M, Shiota T, Lever H M, et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. AmJ Cardiol,2003 ,91:817-821.
  • 6Sherrid M V, Chaudhry F A, Swistel D G. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg, 2003 ,75:620-632.
  • 7Nielsen C D, Spencer W H 3rd. Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy.Cardiol Rev,2002,10 : 108 - 118.
  • 8Freedman R A. Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy.Curr Opin Cardiol, 2001,16:58-65.

同被引文献31

  • 1朱晓东,吴洪斌,胡盛寿,胡宝琏.肥厚性梗阻型心肌病的外科治疗[J].中华胸心血管外科杂志,1997,13(2):73-75. 被引量:5
  • 2Knight C, Kurbsan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertropic obstructive cardiomyopathy: outcome in the first series of patients[J]. Circulation, 1997,95 : 2075-2081.
  • 3Louie EK, Edwards LC. Hypertropic cardiomyopathy[J]. Prog Cardiovase Dis, 1994,36 : 275-308.
  • 4Wigle ED, Rakowski H, Kimbau BP, et al. Hypertropic cardiomyopathy clinical spectrum and treatment [J]. Circulation,1995,92:1680-1692.
  • 5Spirito D, Seidman CB, Mckenna WJ, et al. Management of hypertropic cardiomyopathy[J]. N Englj Med, 1997,3: 775-785.
  • 6Schulte H D,Bo risov K, Gram sch Z H, et al. Management of symptomatic hypertrophic obstructive cardiomyopathy long-term results after surgical therapy[J]. Thorac Cardiovasc Surg, 1999,47: 213-218.
  • 7Seiler C, Hess OM ,Schoenbeck M ,et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy : a retrospective study[J]. J Am Coll Cardiol , 1991,17:634-643.
  • 8Robert A. Surgical versus medical therapy of hypertrophic cardiomyopathy:is the prespective changing [J]. J Am Coll Cardiol, 1991,17: 643-678.
  • 9Firoozi S, Elliott PM, Sharma S, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypetrophic obstructive cardiomyopathy . A comparion of clinical haemodynamic and exercise outcomes[J]. Eur Heart J,2002 ,23:1617-1624.
  • 10Simantirakis EN, Kanoupakis EM, Kochiadakis GE, et al. The effect of DDD pacing on ergospirometric parameters and neurohormonal activity in patients with hypertropic obstructive cardiomyopathy [J]. Pacing Clin Electrophysiol, 1998, 21 : 2269-2272.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部